Olympus and American Lung Association Collaborate on Patient Education for Lung Cancer Screening

Olympus Corporation of the Americas and the American Lung Association are now partnering to educate lung cancer patients about the care pathway for diagnosing and staging lung nodules.

The lung nodules educational resources, sponsored by Olympus, help patients understand the diagnosis and staging process for lung nodules and why it is important to their treatment journey. With this information, patients are empowered to make the best-informed decisions about their own care.

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), a procedure pioneered by Olympus, has helped lay the groundwork for targeted cancer treatment such as immunotherapy. The technology helps pulmonologists locate nodules and lymph nodes and collect the tissue samples needed to diagnose and stage their disease, and this analysis informs the personalized, targeted cancer therapy provided by treatments such as immunotherapy.

Using technologies such as EBUS-TBNA, physicians can tell not only how far lung cancer has spread but also understand the genetic make-up of the cancer cells, which helps physicians recommend the most targeted therapies.

Potential complications associated with endoscopic ultrasound (EUS) include sore throat, infection, bleeding, perforation, and/or tumor seeding (when EUS-fine needle aspiration or biopsy is performed).

To view the source version, please click HERE.

en_GBEnglish (UK)